Patient’s Stage IV Cancer Held in Check by CIRM-Funded Clinical Trial [Video]

TomHowing_Headshot_ScreenShot

Tom Howing

“In the last three scans, which I have every six weeks, they’re showing that there is no mestastasis (invasive cancer) anywhere in my body. [The doctors] I guess were quite blown away because they didn’t expect [the treatment] to be so quick or to be that complete.”

 

Today we’re sharing the story of Tom Howing, who took part in Forty Seven, Inc.’s CIRM-funded clinical trial that’s testing an innovative treatment for cancer.

The two-minute video below sums up Tom’s address to CIRM’s governing Board back in December. During his talk, he gave a personal perspective on his cancer diagnosis, the promising but ultimately disappointing results of standard anti-cancer treatments and the remarkable results he’s experienced from Forty Seven’s clinical trial.

Tom’s story is featured in our 2017 Annual Report (page 18), now available on our website.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s